Author

Cesar Gregorio Muñoz

Observed names: Cesar Muñoz Gregorio, César Muñoz

Institutions: HM Hospitales, Hospital Universitario HM Sanchinarro, Camilo José Cela University

Observed institutions: HM Hospitales, University Hospital HM Puerta del Sur, Hospital Universitario HM Sanchinarro, Fundación de Investigación HM Hospitales, Camilo José Cela University

ORCID: 0000-0003-1959-0306

Observed ORCID: 0000-0003-1959-0306

OpenAlex ID: A5052121745

Romiplostim versus Placebo for Chemotherapy-Induced Thrombocytopenia

2026 · Hanny Al-Samkari, César Muñoz, et al. · New England Journal of Medicine · 22

Long-Term Survival in Hepatocellular Carcinoma following Second-Line Tumor Treating Fields Therapy and Sorafenib: A Case Report

2024 · Marisa Torres Velasco, Rafael Álvarez Gallego, et al. · Case Reports in Oncology · 4

Phase 2, Multicenter, Open-label, Nonrandomized Study of Neoadjuvant Chemotherapy Liposomal Irinotecan With 5-Fluorouracil, Leucovorin, and Oxaliplatin, Followed by Chemoradiotherapy in Patients With Rectal Cancer in a Watch-and-Wait Program

2024 · César Muñoz, María-C. Riesco Martinez, et al. · American Journal of Clinical Oncology · 2

Application of integrated artificial intelligence systems (IAIs) for the identification and study of prognostic and predictive variables of patients with localized rectal cancer treated at HM hospitals.

2022 · Rafael Álvarez, Cesar Gregorio Muñoz, et al. · Journal of Clinical Oncology · 2

Two Randomized Controlled Trials of Romiplostim for Chemotherapy-Induced Thrombocytopenia in Patients with Solid Tumors

2022 · Hanny Al-Samkari, Caglayan Geredeli, et al. · Blood · 1

Prospective study of a multi-modal blood-based test for colorectal cancer screening.

2024 · Paloma Peinado, Enrique Sanz-Garcia, et al. · Journal of Clinical Oncology

Phase II, multicenter, open-label, non-randomized study of neoadjuvant chemotherapy NALIRINOX (5-FU/LV + oxaliplatin + nal-IRI) followed by chemoradiotherapy in patients with rectal cancer in a watch-and-wait program.

2022 · Cesar Gregorio Muñoz, Maria Carmen Riesco Martinez, et al. · Journal of Clinical Oncology

Watch-and-wait policy versus robotic resection in locally advanced rectal cancer patients after clinical complete response following chemoradiotherapy: A cost-effectiveness study (RECCOSTE).

2020 · Jesus Rodriguez-Pascual, Javier Nuñez-Alfonsel, et al. · Journal of Clinical Oncology

Works count: 8

Citation count: 31

H-index: 2

I10-index: 1